BIOLATTI, Matteo
 Distribuzione geografica
Continente #
NA - Nord America 3.788
EU - Europa 2.511
AS - Asia 904
AF - Africa 65
OC - Oceania 45
SA - Sud America 43
Continente sconosciuto - Info sul continente non disponibili 1
Totale 7.357
Nazione #
US - Stati Uniti d'America 3.716
IT - Italia 999
CN - Cina 447
IE - Irlanda 349
SE - Svezia 257
DE - Germania 169
GB - Regno Unito 123
AT - Austria 105
FR - Francia 104
VN - Vietnam 94
UA - Ucraina 90
JP - Giappone 84
IN - India 68
BE - Belgio 61
CA - Canada 51
KR - Corea 50
FI - Finlandia 48
PL - Polonia 44
AU - Australia 38
NL - Olanda 31
TR - Turchia 31
HK - Hong Kong 30
SN - Senegal 29
GR - Grecia 26
TW - Taiwan 19
ES - Italia 18
DK - Danimarca 17
IR - Iran 17
MX - Messico 17
IL - Israele 13
ZA - Sudafrica 12
NO - Norvegia 11
RU - Federazione Russa 11
BR - Brasile 10
IQ - Iraq 10
SI - Slovenia 10
CO - Colombia 9
PH - Filippine 9
PK - Pakistan 9
RO - Romania 9
SG - Singapore 9
TN - Tunisia 9
AR - Argentina 7
NG - Nigeria 7
NZ - Nuova Zelanda 7
PE - Perù 7
CH - Svizzera 6
HR - Croazia 5
CL - Cile 4
PR - Porto Rico 4
SK - Slovacchia (Repubblica Slovacca) 4
LU - Lussemburgo 3
MA - Marocco 3
RS - Serbia 3
ZM - Zambia 3
BD - Bangladesh 2
BG - Bulgaria 2
BY - Bielorussia 2
EC - Ecuador 2
GY - Guiana 2
ID - Indonesia 2
MY - Malesia 2
SA - Arabia Saudita 2
TH - Thailandia 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
CZ - Repubblica Ceca 1
EG - Egitto 1
EU - Europa 1
IS - Islanda 1
JO - Giordania 1
LB - Libano 1
MU - Mauritius 1
NP - Nepal 1
PT - Portogallo 1
UY - Uruguay 1
YE - Yemen 1
Totale 7.357
Città #
Chandler 849
Dublin 349
Torino 205
Fairfield 180
Beijing 170
Ann Arbor 129
Houston 120
Woodbridge 116
Sovicille 115
Nyköping 114
Redwood City 100
Vienna 98
Jacksonville 91
Wilmington 85
Princeton 80
Cambridge 79
Ashburn 78
Medford 72
Pisa 70
Seattle 68
Turin 68
Dong Ket 65
Dearborn 62
Villeurbanne 59
Guangzhou 52
Boston 44
Brussels 44
Fremont 41
Rome 41
Warsaw 36
Washington 32
Norwalk 26
Milan 25
Hebei 24
Maddaloni 22
San Diego 21
Taipei 19
Los Angeles 15
Tokyo 15
Boardman 14
Hangzhou 14
Seoul 14
Thebes 14
Rochester 13
Shanghai 13
Toronto 13
Wuhan 13
Hefei 12
Ipswich 12
Munich 12
Nanjing 12
Piemonte 12
Aarhus 11
Melbourne 11
San Mateo 11
Dallas 10
Hanover 10
Istanbul 10
London 10
Casteggio 9
Lincoln 9
Ottawa 9
Utrecht 9
Boffalora sopra Ticino 8
Bogotá 8
Changsha 8
Florence 8
Fossano 8
Hamburg 8
Novara 8
Berlin 7
Kahramanmaraş 7
Kraainem 7
Kunming 7
Minneapolis 7
Oslo 7
San Mauro Torinese 7
Suri 7
Vaasa 7
Vercelli 7
Alessandria 6
Avigliana 6
Baltimore 6
Bologna 6
Central 6
Falls Church 6
Jinan 6
Johannesburg 6
Lima 6
Philadelphia 6
Redmond 6
Seabrook 6
Upper Marlboro 6
Bethesda 5
Cassano Magnago 5
Chengdu 5
Genova 5
Leawood 5
Leiden 5
New York 5
Totale 4.395
Nome #
ANALISI DELLA RISPOSTA IMMUNITARIA INNATA IN CHERATINOCITI UMANI DOPO INFEZIONE CON CITOMEGALOVIRUS . 301
The human cytomegalovirus tegument protein pp65 (pUL83): a key player in innate immune evasion 243
Biological relevance of Cytomegalovirus genetic variability in congenitally and postnatally infected children. [*Dell'Oste V, *Landolfo S, co-corresponding authors] 243
The DNA Cytosine Deaminase APOBEC3G is upregulated during Human Cytomegalovirus infection 191
PYHIN genes as potential biomarkers for prognosis of human papillomavirus-positive or -negative head and neck squamous cell carcinomas. 187
Differential expression of HER2, STAT3, SOX2, IFI16 and cell cycle markers during HPV-related head and neck carcinogenesis 186
IL GENE INTERFERON-INDUCIBILE IFI16: POTENZIALE FATTORE ANTIVIRALE E MARCATORE DIAGNOSTICO DELLE INFEZIONI DA PAPILLOMAVIRUS UMANI 177
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability [*Biolatti M, *Dell'Oste V, co-first authors] 161
The Human Cytomegalovirus Tegument Protein pp65 (pUL83) Dampens Type I Interferon Production by Inactivating the DNA Sensor cGAS without Affecting STING [*Biolatti M, Dell'Oste V* co-first authors] 161
Innate Nuclear Sensor IFI16 Translocates into the Cytoplasm during the Early Stage of In Vitro Human Cytomegalovirus Infection and Is Entrapped in the Egressing Virions during the Late Stage. 161
The human Cytomegalovirus tegument protein pp65 (pUL83) dampens interferon-type I production by inactivating the DNA sensor cGAS 156
NUOVO MECCANISMO DI EVASIONE DEL CITOMEGALOVIRUS UMANO DAL FATTORE DI RESTRIZIONE IFI16. 152
Citrullination during Human Cytomegalovirus infection: implications for autoimmune diseases 147
CHARACTERIZATION OF POST-TRANSLATIONAL MODIFICATIONS DURING HUMAN CYTOMEGALOVIRUS INFECTION: IMPLICATIONS FOR NOVEL ANTIVIRALS 141
Modulation of the innate immune response by human cytomegalovirus. [*Dell'Oste V., Landolfo S. co-corresponding authors] 141
Genotypic analysis of HCMV polymorphism in congenital infections to predict the impact of HCMV disease severity in newborns/infants 129
Catch me if you can: the arms race between human cytomegalovirus and the innate immune system [Ganna Galitska*, Matteo Biolatti*, equal contribution) 129
Strigolactones as antiviral drugs to inhibit Herpesvirus replication 127
Strigolactone analogs are promising antiviral agents against Herpesviruses 118
Past and ongoing adaptation of human cytomegalovirus to its host. 115
Evasion strategy of Human Cytomegalovirus from the antiviral activities of APOBEC3G 114
Regulatory interaction between the cellular restriction factor IFI16 and viral pp65 (pUL83) modulates viral gene expression and IFI16 protein stability 113
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity. [*Biolatti M, *Dell'Oste V, co-first authors] 112
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 110
A Conserved Mechanism of APOBEC3 Relocalization by Herpesviral Ribonucleotide Reductase Large Subunits. 105
Strategy of Human Cytomegalovirus To Escape Interferon Beta-Induced APOBEC3G Editing Activity 103
HPV meets APOBEC: New players in head and neck cancer [*Biolatti M, Dell'Oste V* co-last authors]. 101
HUMAN CYTOMEGALOVIRUS INFECTION TRIGGERS THE INTERFERON RESPONSE VIA THE DNA SENSOR IFI16 IN HUMAN KERATINOCYTES 98
Metabolic Games: IFI16-Driven Regulation of Cellular Metabolism upon HCMV Infection 98
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis 95
Where do we stand after decades of studying human cytomegalovirus? 95
A leopard can change its spots: how HCMV genetic variability impacts viral fitness and NK ligands immunomodulation 93
Early stage IFI16 cytoplasmic translocation and late stage entrapment into egressing virions during HCMV infection 92
IFI16 Impacts Metabolic Reprogramming during Human Cytomegalovirus Infection [*Valentina Dell'Oste, *Matteo Biolatti, co-corresponding authors] 88
A NOVEL MECHANISM OF HUMAN CYTOMEGALOVIRUS EVASION FROM RESTRICTION FACTOR IFI16. 84
Evasion Strategy of Human Cytomegalovirus to Escape Interferon-β-Induced APOBEC3G Editing Activity 84
COMPARATIVE ANALYSIS OF HUMAN CYTOMEGALOVIRUS CLINICAL ISOLATES FROM KIDNEY TRANSPLANT RECIPIENTS 82
HCMV TEGUMENT PROTEINS: NEW INSIGHTS ON INTERACTION BETWEEN THE DNA SENSOR PROTEIN IFI16 AND VIRION PARTICLES 82
Human cytomegalovirus-induced host protein citrullination is crucial for viral replication 81
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection. 80
IFI16 is a Negative Regulator of Glucose and Cellular Lipid Metabolism during Human Cytomegalovirus Infection 79
Tuning the Orchestra: HCMV vs. Innate Immunity. 78
The Viral Tegument Protein pp65 Impairs Transcriptional Upregulation of IL-1β by Human Cytomegalovirus through Inhibition of NF-kB Activity 77
Risk of Symptomatic Infection after Non-Primary Congenital Cytomegalovirus Infection 76
Human Cytomegalovirus and Autoimmune Diseases: Where Are We? 76
The interferon-inducible DNA-sensor protein IFI16: a key player in the antiviral response 75
Regulatory Interaction between the Cellular Restriction Factor IFI16 and Viral pp65 (pUL83) Modulates Viral Gene Expression and IFI16 Protein Stability 73
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 72
Synthesis and Biological Evaluation of Amidinourea Derivatives against Herpes Simplex Viruses [*Valentina Dell'Oste, Daniele Castagnolo: co-corresponding authors] 70
The IFI16 restriction factor cooperates with HCMV pUL83 to down-regulate UL54 gene expression and viral DNA synthesis. 68
PAD2 FOR USE IN DIAGNOSING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY AND INHIBITORS OR ANTAGONISTS OF PAD2 FOR USE AS ANTI-VIRAL AGENTS AGAINST VIRUSES OF THE HERPESVIRIDAE FAMILY 68
Peptidyl Arginine Deiminases: a Novel Antiviral Target against Human Cytomegalovirus 67
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 65
SAMHD1 phosphorylation and cytoplasmic relocalization after human cytomegalovirus infection limits its antiviral activity 64
NOVEL ANTIVIRAL ACTIVITY OF PADs INHIBITORS AGAINST BETA-CORONAVIRUSES SARS-CoV-2 AND HCoV-OC43 63
Novel antiviral activity of PADs inhibitors against human beta-coronaviruses SARS-CoV-2 and HCoV-OC43 59
Human Cytomegalovirus pp65 inhibits Interferon type I production through its interaction with the cGAS/STING axis 58
PYHIN Proteins and HPV: Role in the Pathogenesis of Head and Neck Squamous Cell Carcinoma 56
Metabolic games: IFI16-driven regulation of cellular metabolism upon HCMV infection 55
Targeting PAD-mediated citrullination to treat human papillomavirus infections 54
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 52
STRIGOLACTONES FOR USE IN PREVENTING AND/OR TREATING INFECTIONS CAUSED BY VIRUSES OF THE HERPESVIRIDAE FAMILY 50
45th International Herpesvirus Workshop 50
Herpes simplex virus type 1 induced citrullination in neuronal cells suggests new therapeutic options for the treatment of virus-associated neurodegenerative disorders 49
Strigolactone analogs are promising antiviral agents for the treatment of human cytomegalovirus infection 49
Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ 47
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting the main protease Mpro 46
Strigolactone Analogs Are Promising Antiviral Agents for the Treatment of Human Cytomegalovirus Infection 46
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer's disease. 44
THE GENETIC VARIABILITY OF HUMAN CITOMEGALOVIRUS: POSSIBLE IMPLICATIONS IN CLINICAL, IMMUNOLOGICAL AND VIROLOGICAL SETTINGS 44
Strigolactones as broad-spectrum antivirals against β-coronaviruses through targeting SARS-CoV-2 Mpro 43
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 40
A Leopard Can Change Its Spots: How HCMV Genetic Variability Impacts Viral Fitness and NK Ligands Immunomodulation 39
Targeting PAD-mediated citrullination to treat human papillomavirus infections 38
CONGENITAL CYTOEGALOVIRUS INFECTION: CAN THE DIFFERENCE BETWEEN THE VIRUS’ RELATIONSHIP WITH THE HOST’S IMMUNE SYSTEM EXPLAIN THE DIFFERENCE IN CLINICAL PHENOTYPES? 38
NOVEL ANTIVIRAL ACTIVITY OF PADS INHIBITORS AGAINST HUMAN BETA-CORONAVIRUSES SARS-COV-2 AND HCOV-OC43 33
Exploiting lipid metabolism by HSV-1 – a challenge to rethink new therapies for Alzheimer's disease 32
50° Congresso Nazionale della Società Italiana di Microbiologia 31
La variabilità genetica del citomegalovirus umano: possibili implicazioni dal punto di vista clinico, immunologico e virologico 29
IFI16 impacts metabolic reprogramming during human cytomegalovirus infection 28
IFI16 IMPACTS METABOLIC REPROGRAMMING DURING HUMAN CYTOMEGALOVIRUS INFECTION 27
Strigolactones as broad-spectrum antivirals against ß-coronaviruses through targeting the main protease Mpro 26
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 25
IFI16 Impacts Metabolic Reprogramming During Human Cytomegalovirus Infection 23
Strigolactones as Broad-Spectrum Antivirals against β-Coronaviruses through Targeting the Main Protease Mpro 12
Exploiting lipid metabolism by HSV-1: a challenge to rethink new therapies for Alzheimer’s disease 9
Exploiting Lipid Metabolism by HSV-1: a Challenge to Rethink New Therapies for Alzheimer’s Disease 7
HSV-1-induced PAD-mediated Citrullination as a New Target for Antiviral Therapy 5
Herpesvirus-mediated protein citrullination as a new target for antiviral therapy 5
Replication properties and immunomodulatory effects of human cytomegalovirus infection impact the clinical presentation in congenital patients: A case series 4
Characterization of citrullination during infection with DNA and RNA viruses: a new strategy for host-targeting antivirals drugs 4
Novel antiviral activity of PAD inhibitors against human beta-coronaviruses HCoV-OC43 and SARS-CoV-2 3
Totale 7.607
Categoria #
all - tutte 16.322
article - articoli 0
book - libri 0
conference - conferenze 9.512
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 25.834


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019572 0 0 69 58 41 23 29 80 44 79 98 51
2019/2020852 18 21 52 102 38 110 91 68 77 104 71 100
2020/20211.166 72 69 66 58 97 118 132 75 84 152 67 176
2021/20221.294 75 71 91 128 70 54 61 69 45 92 324 214
2022/20232.425 130 143 56 279 255 537 134 212 326 73 147 133
2023/2024441 173 175 93 0 0 0 0 0 0 0 0 0
Totale 7.607